tween anticoagulant therapy for atrial fibrillation and risk of falling among elderly people. His
Markov decision analytic model suggests that the benefit–risk ratio favours using …

Abstract Background and Objective The decision to initiate anticoagulation in older adults
with atrial fibrillation is complicated by the benefit of ischemic stroke prevention vs the risk of …

Background The benefits of warfarin therapy in stroke prevention have been demonstrated
in other trials.[1] Warfarin therapy is not without risk, and clinicians are especially concerned …

OBJECTIVE: To evaluate data addressing use of anticoagulation in elderly patients with
atrial fibrillation (AF), in particular those at risk of falls. DATA SOURCES: Primary literature …

Atrial fibrillation (AF) is a major global health burden because of its rising prevalence and
associated complications such as stroke and mortality. 1 In the 2010 Global Burden of …

Objective To determine whether the risk of falling (with a possible increased chance of
subdural hematoma) should influence the choice of antithrombotic therapy in elderly …

Guidelines for managing atrial fibrillation recommend systemic anticoagulation for almost all
patients age 65 and older, but in practice up to 50% of older patients do not receive …

Atrial fibrillation (AF) affects 2.5 million patients in the United States. The incidence of this
condition increases with age, such that approximately 5% of people> 65 years of age have …

In clinical practice many patients with atrial fibrillation (AF) at high thromboembolic risk fail to
receive adequate oral anticoagulation (OAC)[1]. The complex management of anticoagulant …

OBJECTIVES: To better understand the tradeoffs between the efficacy of anticoagulation
with warfarin and its side effects in the oldest old with nonrheumatic atrial fibrillation (AF) …